Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges
- 3 January 2007
- Vol. 25 (15) , 2787-2799
- https://doi.org/10.1016/j.vaccine.2006.12.037
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory ChallengeJournal of Virology, 2005
- Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in MiceJournal of Virology, 2005
- An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia modelJournal of General Virology, 2005
- Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell PopulationScience, 2004
- Development and Use of a Vaccinia Virus Neutralization Assay Based on Flow Cytometric Detection of Green Fluorescent ProteinJournal of Virology, 2003
- Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivoNature Immunology, 2002
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humansPublished by Elsevier ,2001
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory routeJournal of General Virology, 1990
- Immunobiological activities of nontoxic lipid A: Enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effectsInternational Journal of Immunopharmacology, 1986